Organs

Kerecis Educational Webinars Focus on Omega3 Rich Fish Skin for Wound Care

Retrieved on: 
Monday, May 25, 2020

Kerecis , the company pioneering the use of fish skin and fatty acids in tissue regeneration and tissue protection, will present three educational lectures on wound care in May and June.

Key Points: 
  • Kerecis , the company pioneering the use of fish skin and fatty acids in tissue regeneration and tissue protection, will present three educational lectures on wound care in May and June.
  • The need for wound care did not disappear with the appearance of COVID-19, said Joe Smith, Executive Vice President of Marketing and Strategic Alliances at Kerecis.
  • Kerecis Omega3 Wound is intact fish skin that, when grafted onto damaged human tissue, recruits the bodys own cells and ultimately is converted into living tissue.
  • Because no disease-transfer risk exists between cold-water fish and humans, the Kerecis fish skin is only gently processed and retains its similarity to human skin, making it an ideal skin substitute.

Kitchen Brains® launches USA2020 with $1+ million investment in Connecticut factory

Retrieved on: 
Wednesday, May 20, 2020

At the core of USA2020 is Kitchen Brains deep commitment to its manufacturing operations in the United States.

Key Points: 
  • At the core of USA2020 is Kitchen Brains deep commitment to its manufacturing operations in the United States.
  • With this investment, Kitchen Brains will provide customers with new capabilities, faster build times and greater accuracy.
  • In addition, the added capacity will enable Kitchen Brains to offer contract manufacturing to support current and new business partners in foodservice and other industries.
  • As the economy strengthens, Kitchen Brains will be well positioned to further lead the industry for controllers, monitors and new products that are currently in development."

Kitchen Brains® launches USA2020 with $1+ million investment in Connecticut factory

Retrieved on: 
Wednesday, May 20, 2020

At the core of USA2020 is Kitchen Brains deep commitment to its manufacturing operations in the United States.

Key Points: 
  • At the core of USA2020 is Kitchen Brains deep commitment to its manufacturing operations in the United States.
  • With this investment, Kitchen Brains will provide customers with new capabilities, faster build times and greater accuracy.
  • In addition, the added capacity will enable Kitchen Brains to offer contract manufacturing to support current and new business partners in foodservice and other industries.
  • As the economy strengthens, Kitchen Brains will be well positioned to further lead the industry for controllers, monitors and new products that are currently in development."

Mercaptor Discoveries Uses its Proprietary Neurotherapeutic Platform to Develop Treatment for COVID-19

Retrieved on: 
Monday, May 18, 2020

NOVATO, Calif., May 18, 2020 /PRNewswire/ -- Mercaptor Discoveries (Mercaptor), a platform company with preclinical programs in epilepsy and TBI, today announced that it is pivoting its proprietary neurotherapeutic development plan toward COVID-19.

Key Points: 
  • NOVATO, Calif., May 18, 2020 /PRNewswire/ -- Mercaptor Discoveries (Mercaptor), a platform company with preclinical programs in epilepsy and TBI, today announced that it is pivoting its proprietary neurotherapeutic development plan toward COVID-19.
  • Responding to the danger of brain damage caused by COVID-19, Mercaptor is directing its proprietary neurotherapeutic platform toward the development of drugs that prevent or relieve the worst effects of the virus.
  • "With Capton technology, injury-activated localized-treatment is now possible, allowing for precision medicine in the brain," said Sara Isbell, CEO, President and Co-Founder, Mercaptor Discoveries.
  • Mercaptor Discoveries was founded by a scientific team that has experience developing successful biotech companies, including Raptor Pharmaceuticals.

Study Shows BioCell Collagen Ingestion Reduced Signs of UVB-Induced Photoaging, Which Accounts for a Significant Amount of Visible Skin Damage

Retrieved on: 
Wednesday, April 29, 2020

Photoaging skin damage caused by exposure to sunlight and ultraviolet (UV) light is responsible for 90 percent of visible changes to the skin1.

Key Points: 
  • Photoaging skin damage caused by exposure to sunlight and ultraviolet (UV) light is responsible for 90 percent of visible changes to the skin1.
  • Conducted by an independent research team, the study evaluated the use of BioCell Collagen in hairless mice, which have skin absorption levels comparable to human skin.
  • The skin was measured and graded to determine the efficacy of BioCell Collagen on measurements of wrinkles, transepidermal water loss, skin elasticity and collagen levels.
  • While BioCell Collagen cannot replace your sunscreen, this study is further evidence that BioCell Collagen can serve as a safe, easy-to-take, non-invasive addition to a skin care regimen.

Study Shows BioCell Collagen Ingestion Reduced Signs of UVB-Induced Photoaging, Which Accounts for a Significant Amount of Visible Skin Damage

Retrieved on: 
Tuesday, April 28, 2020

Photoaging skin damage caused by exposure to sunlight and ultraviolet (UV) light is responsible for 90 percent of visible changes to the skin1.

Key Points: 
  • Photoaging skin damage caused by exposure to sunlight and ultraviolet (UV) light is responsible for 90 percent of visible changes to the skin1.
  • Conducted by an independent research team, the study evaluated the use of BioCell Collagen in hairless mice, which have skin absorption levels comparable to human skin.
  • The skin was measured and graded to determine the efficacy of BioCell Collagen on measurements of wrinkles, transepidermal water loss, skin elasticity and collagen levels.
  • While BioCell Collagen cannot replace your sunscreen, this study is further evidence that BioCell Collagen can serve as a safe, easy-to-take, non-invasive addition to a skin care regimen.

The Combined Power of Topical and Internal Skin Therapy

Retrieved on: 
Tuesday, April 28, 2020

Hyaluronic acid is a type of sugar, naturally occurring in the human body, which is most abundant in the skin.

Key Points: 
  • Hyaluronic acid is a type of sugar, naturally occurring in the human body, which is most abundant in the skin.
  • DERMALUX is a highly concentrated collagen formula, created to be easily absorbed into the body, revitalizing hair, skin, and nails.
  • For this reason, Revelox also makes a topical serum, HYDRALUX, to offer deep external moisturizing nutrition, repairing and caring for all types of skin.
  • In addition to hyaluronic acid, HYDRALUX also contains a host of botanical ingredients cultivated for external skin therapy.

Outlook on the Worldwide Gaucher Disease Treatment Industry to 2027 - Europe Accounted for Around 28% Market Share in 2018 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, April 28, 2020

The "Global Gaucher Disease Treatment Market Outlook 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Gaucher Disease Treatment Market Outlook 2027" report has been added to ResearchAndMarkets.com's offering.
  • Gaucher disease (GD) refers to the accumulation of glucocerebroside in cells and certain organs leading to the enlargement of the liver and spleen.
  • The global Gaucher disease market is anticipated to record a CAGR of around 3% over the forecast period, i.e.
  • Based on region, the global Gaucher disease market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Global Human Liver Models Industry

Retrieved on: 
Monday, April 27, 2020

US Human Liver Models Market Share (in %) by Company: 2019 & 2025

Key Points: 
  • US Human Liver Models Market Share (in %) by Company: 2019 & 2025
    Projections in US$ Thousand by Type: 2018 to 2025
    Forecasts in US$ Thousand by Type: 2018 to 2025
    Table 24: Human Liver Models Market in Canada: Percentage Share
    Breakdown of Sales by Type for 2009, 2019, and 2025
    Table 25: Japanese Market for Human Liver Models: Annual Sales
    Table 26: Human Liver Models Market in Japan: Historic Sales
    in US$ Thousand by Type: 2009-2017
    Table 30: Chinese Human Liver Models Market by Type: Percentage
    Breakdown of Sales for 2009, 2019, and 2025
    European Human Liver Models Market: Competitor Market Share
    Table 32: Human Liver Models Market in Europe: A Historic
    Forecasts in US$ Thousand by Type: 2018-2025
    Table 37: Human Liver Models Market in France by Type:
    Table 40: Human Liver Models Market in Germany: Recent Past,
    in US$ Thousand by Type: 2009-2017
    Table 45: Italian Human Liver Models Market by Type: Percentage
    Breakdown of Sales for 2009, 2019, and 2025
    Table 46: United Kingdom Market for Human Liver Models: Annual
    Table 47: Human Liver Models Market in the United Kingdom:
    Forecasts in US$ Thousand by Type: 2018 to 2025
    Table 51: Human Liver Models Market in Spain: Percentage Share
    Breakdown of Sales by Type for 2009, 2019, and 2025
    Projections in US$ Thousand by Type: 2018 to 2025
    Table 53: Human Liver Models Market in Russia by Type:
    and Forecasts in US$ Thousand by Type: 2018-2025
    Forecasts in US$ Thousand by Region/Country: 2018-2025
    Table 59: Human Liver Models Market in Asia-Pacific: Historic
    Table 61: Human Liver Models Market in Asia-Pacific by Type:
    Scenario in US$ Thousand by Type: 2009-2017
    Table 64: Human Liver Models Market in Australia: Recent Past,
    Analysis in US$ Thousand by Type: 2009-2017
    Forecasts in US$ Thousand by Type: 2018 to 2025
    Table 69: Human Liver Models Market in India: Percentage Share
    Breakdown of Sales by Type for 2009, 2019, and 2025
    Table 70: Human Liver Models Market in South Korea: Recent
    Analysis in US$ Thousand by Type: 2009-2017
    Table 73: Rest of Asia-Pacific Market for Human Liver Models:
    Table 74: Human Liver Models Market in Rest of Asia-Pacific:
    Breakdown of Sales by Region/Country: 2009, 2019, and 2025
    America in US$ Thousand by Type: 2009-2017
    Table 81: Latin American Human Liver Models Market by Type:
    Percentage Breakdown of Sales for 2009, 2019, and 2025
    Forecasts in US$ Thousand by Type: 2018-2025
    Table 85: Human Liver Models Market in Brazil by Type:
    in US$ Thousand by Type: 2009-2017
    Table 88: Human Liver Models Market in Mexico: Recent Past,
    in US$ Thousand by Type: 2009-2017
    Estimates and Projections in US$ Thousand by Type: 2018 to 2025
    and Forecasts in US$ Thousand by Region/Country: 2018-2025
    and Forecasts in US$ Thousand by Type: 2018 to 2025
    Table 99: Human Liver Models Market in the Middle East:
    Percentage Share Breakdown of Sales by Type for 2009, 2019, and
    Table 100: Iranian Market for Human Liver Models: Annual Sales
    Table 101: Human Liver Models Market in Iran: Historic Sales
    Forecasts in US$ Thousand by Type: 2018-2025
    Arabia in US$ Thousand by Type: 2009-2017
    Table 108: Saudi Arabian Human Liver Models Market by Type:
    Percentage Breakdown of Sales for 2009, 2019, and 2025
    Market Analysis in US$ Thousand by Type: 2009-2017
    United Arab Emirates by Type: 2009 VS 2019 VS 2025
    Table 112: Human Liver Models Market in Rest of Middle East:
    Market Analysis in US$ Thousand by Type: 2009-2017
    Projections in US$ Thousand by Type: 2018 to 2025
    Table 116: Human Liver Models Market in Africa by Type:

OncoSec Presents Pre-Clinical Data from Its Visceral Lesion Applicator (VLA) and APOLLO Feasibility Study Demonstrating TAVO™ Can Be Safely Delivered and Electroporated in Liver at the Online Society of Interventional Radiology Annual Meeting

Retrieved on: 
Tuesday, April 21, 2020

In the study presented online at the Annual Meeting of the SIR, OncoSec demonstrated the ability to guide and deploy the VLA under a different guidance method and electroporate with the APOLLO generator.

Key Points: 
  • In the study presented online at the Annual Meeting of the SIR, OncoSec demonstrated the ability to guide and deploy the VLA under a different guidance method and electroporate with the APOLLO generator.
  • Using CT-guidance, investigators were able to reach high value targets including liver, lung, bone, and pancreas in a live large animal model.
  • Additionally, TAVO was safely delivered and electroporated directly into the liver.
  • Importantly, data also showed that it had no significant effects on hemodynamics, as indicated by consistent heart rate and arterial blood pressure.